The global synthetic biology market is expected to cross US$ 45 billion by 2021, registering a compound annual growth rate (CAGR) of 44.2% during the forecast period. The financial support and assistance from government and private organizations and the increasing number of individual conducting research are expected to drive the market. In addition, the growing number of industries entering the market and declining price of DNA sequencing drives the synthetic biology market. However, the creation of stringent regulatory bodies and ethical and societal issues are expected to hamper the growth of the market.
In this report, the global synthetic biology market is segmented by tool, technology, application, and region. On the basis of tool, the market is segmented into xeno-nucleic acids (XNAs), chassis organisms, oligonucleotides, enzymes, and cloning technology kits. The market on the basis of technology is segmented into enabled and enabling technologies. The market is segmented on the basis of application into environmental, medical, and industrial.
The global synthetic biology market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Russia, Brazil, and GCC countries. The report includes a detailed study of the global and regional synthetic biology market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
BASF, GEN9 Inc., Algenol Biofuels, Codexis Inc., GenScript Corporation, DuPont, Butamax Advanced Biofuels, BioAmber, Biosearch Technologies, Inc., OriGene Technologies, Inc., Synthetic Genomics, Inc., GeneArt (Life Technologies), GENEWIZ, Inc., Eurofins Scientific, Inc., Integrated DNA Technologies, Inc., DNA2.0, Inc., Pareto Biotechnologies, Synthorx, Inc., TeselaGen Biotechnology, Editas Medicine, Inc., Twist Bioscience1, GeneWorks Pty Ltd., Proterro, Inc., and Blue Heron (OriGene Technologies Inc.) are the most active players in the synthetic biology market.
This report covers the synthetic biology market, in terms of value, and forecasts the market size till 2020. It includes the market segmentation by tool, technology, application, and region. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
This deep-dive study on the synthetic biology market will help customers with the identification of new market opportunities and targeted promotional plans.